Company Overview of University of Birmingham
A U.K. university, is active in life science research and technology transfer to the private sector
Birmingham, B15 2TT
Founded in 1900
Key Executives for University of Birmingham
University of Birmingham does not have any Key Executives recorded.
University of Birmingham Key Developments
Cell Therapy Catapult, University of Birmingham and Cancer Research Technology Launch New Collaboration for CAR-T Cell Immuno-Oncology Therapy Development
Jan 6 16
The Cell Therapy Catapult, the University of Birmingham and Cancer Research Technology, the commercialization arm of Cancer Research UK, announced the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours. The project is aimed at translating an academic discovery programme funded by Cancer Research UK and developed by Dr. Steven Lee and Prof Roy Bicknell at the University of Birmingham into a commercially viable cell therapy. The collaborating partners have launched a new company, Chimeric Therapeutics Ltd. This new company will hold all future IP rights to the resultant discoveries. The project is based on a new generation chimeric antigen receptor T-Cell (CAR-T) immuno-oncology therapy for solid tumours. This involves directing the CAR-T cell towards a new, highly specific marker of tumour angiogenesis, CLEC14a. This therapy will act as a vasculature disruptive agent compromising oxygen supply to the tumours and inhibiting tumour growth. The technology is currently undergoing the final stages of preclinical development, and is planned to enter into clinical trials soon after. Cancer Research Technology and the University of Birmingham have partnered with The Cell Therapy Catapult to bring their extensive regulatory, clinical, analytical and manufacturing process development expertise into the program, utilizing their experience in developing immunotherapies for cancer. The Cell Therapy Catapult will specifically be involved in the project to accelerate the translation of the academic discoveries made in Birmingham with Cancer Research Technology around CAR-T immunotherapies for solid tumours and the CLEC14a target towards a commercially available cell therapy.
University of Birmingham and Beijing Jiaotong University Signs Research Cooperation Agreement
Sep 21 15
The University of Birmingham and Beijing Jiaotong University (BJTU) have signed a research cooperation agreement that announced plans for a joint international high-speed railway research laboratory. The new research lab will be run jointly by the Birmingham Centre for Railway Research and Education (BCRRE) at the University of Birmingham - which offers the academic research and education capability for railways in the UK - and the State Key Lab of Rail Traffic Control and Safety at BJTU. The joint lab is expected to be developed as part of a wider UK-China high-speed railway research platform which will eventually bring together experienced railway researchers from other institutions from both nations with railway expertise. The aim is for the platform to deliver, in partnership, leading railway research for the global industry. The University of Birmingham has a history of research and collaboration with BJTU, especially in the area of railways. There have already been several academic exchanges between the two universities, which have come as a result of joint research projects funded by both the governments and industry of the UK and China. The Sino-UK Higher Education Research Partnership for PhD studies project supports the exchange of six researchers and six students between both the University of Birmingham and BJTU who work on advanced technologies to improve capacity and reduce consumption for metro systems.
University of Birmingham Announces Directorate Changes
Jan 19 15
The University of Birmingham announced the appointment of Dr. Judith Smith as the new Director of the Health Services Management Centre, succeeding Professor Jon Glasby. Dr. Smith joins the University from leading independent charitable research foundation the Nuffield Trust, where she has spent six years as Director of Policy. Prior to joining the Trust, Smith spent 14 years at HSMC, holding the positions of Senior Lecturer, Director of Research, and Academic Director of the NHS Management Training Scheme. From 2007 to 2009, Judith was based in New Zealand at the Victoria University of Wellington and the New Zealand Ministry of Health. Early in her career she was a senior manager in the NHS.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries